ArticleBMJ open diabetes research & care2021

Metabolomics-based multidimensional network biomarkers for diabetic retinopathy identification in patients with type 2 diabetes mellitus.

Jingjing Zuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.